Efficacy and Safety of SHR-1314 in Patients With Active Ankylosing Spondylitis
Status:
Recruiting
Trial end date:
2024-03-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess efficacy, safety, pharmacokinetics and immunogenicity
of subcutaneous SHR-1314 in patients with active ankylosing spondylitis